Skip to content
Catalyst

PapersPMID:20140804

Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.

Natural product research2010The record ↗

findings
3
compound
1
endpoints
3
PMID:20140804
  1. Finding, insufficient evidenceraisesHDL cholesterol
  2. Finding, insufficient evidencelowersLDL cholesterol
  3. Finding, insufficient evidencelowersTotal cholesterol (TC)
Study, every finding
animal · not in humans
Dose studied, every finding
4-hydroxyisoleucine 50 mg/kg orally
Population, every finding
C57BL/KsJ-db/db mice, a model of type II diabetes
  • “4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”

Study record

Design
animal study, in vivo
Species
animal
Population
C57BL/KsJ-db/db mice (type II diabetes model); 4-hydroxyisoleucine isolated from Trigonella foenum-graecum seeds, given orally
Participants
not reported
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
6